Literature DB >> 25009445

Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.

Ted Lee1, Neil Mendhiratta1, Dan Sperling2, Herbert Lepor1.   

Abstract

Focal therapy of prostate cancer is an evolving treatment strategy that destroys a predefined region of the prostate gland that harbors clinically significant disease. Although long-term oncologic control has yet to be demonstrated, focal therapy is associated with a marked decrease in treatment-related morbidity. Focal laser ablation is an emerging modality that has several advantages, most notably real-time magnetic resonance imaging (MRI) compatibility. This review presents the principles of laser ablation, the role of multiparametric MRI for delineating the site of significant prostate cancer, a summary of published clinical studies, and our initial experience with 23 patients, criteria for selecting candidates for focal prostate ablation, and speculation regarding future directions.

Entities:  

Keywords:  Focal therapy; Laser ablation; Prostate cancer; Targeted therapy

Year:  2014        PMID: 25009445      PMCID: PMC4080850     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  39 in total

Review 1.  Photodynamic therapy for focal ablation of the prostate.

Authors:  Nimalan Arumainayagam; C M Moore; Hashim U Ahmed; M Emberton
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

2.  Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy.

Authors:  Nicholas M Donin; Juliana Laze; Ming Zhou; Qinghu Ren; Herbert Lepor
Journal:  Urology       Date:  2013-05-22       Impact factor: 2.649

Review 3.  Focal laser ablation for localized prostate cancer.

Authors:  Uri Lindner; Nathan Lawrentschuk; John Trachtenberg
Journal:  J Endourol       Date:  2010-05       Impact factor: 2.942

4.  Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.

Authors:  Duke Bahn; Andre Luis de Castro Abreu; Inderbir S Gill; Andrew J Hung; Paul Silverman; Mitchell E Gross; Gary Lieskovsky; Osamu Ukimura
Journal:  Eur Urol       Date:  2012-03-21       Impact factor: 20.096

5.  Low-power laserthermia for the treatment of small hepatocellular carcinoma.

Authors:  G T Huang; T H Wang; J C Sheu; N Daikuzono; J L Sung; M Z Wu; D S Chen
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

6.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

7.  Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.

Authors:  Masanori Noguchi; Thomas A Stamey; John E McNeal; Rosalie Nolley
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

8.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial.

Authors:  U Lindner; R A Weersink; M A Haider; M R Gertner; S R H Davidson; M Atri; B C Wilson; A Fenster; J Trachtenberg
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

9.  Focal laser ablation of prostate cancer: definition, needs, and future.

Authors:  Pierre Colin; Serge Mordon; Pierre Nevoux; Mohammed Feras Marqa; Adil Ouzzane; Philippe Puech; Gregory Bozzini; Bertrand Leroux; Arnauld Villers; Nacim Betrouni
Journal:  Adv Urol       Date:  2012-05-16

10.  Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:  Wennuan Liu; Sari Laitinen; Sofia Khan; Mauno Vihinen; Jeanne Kowalski; Guoqiang Yu; Li Chen; Charles M Ewing; Mario A Eisenberger; Michael A Carducci; William G Nelson; Srinivasan Yegnasubramanian; Jun Luo; Yue Wang; Jianfeng Xu; William B Isaacs; Tapio Visakorpi; G Steven Bova
Journal:  Nat Med       Date:  2009-04-12       Impact factor: 53.440

View more
  17 in total

Review 1.  Current trends and new frontiers in focal therapy for localized prostate cancer.

Authors:  Melissa H Mendez; Daniel Y Joh; Rajan Gupta; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

Review 2.  Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Abdom Radiol (NY)       Date:  2016-05

3.  Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Clin Transl Imaging       Date:  2017-04-10

Review 4.  Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.

Authors:  Baris Turkbey; Anna M Brown; Sandeep Sankineni; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  CA Cancer J Clin       Date:  2015-11-23       Impact factor: 508.702

5.  Estimation of optical properties of neuroendocrine pancreas tumor with double-integrating-sphere system and inverse Monte Carlo model.

Authors:  Paola Saccomandi; Enza Stefania Larocca; Veneranda Rendina; Emiliano Schena; Roberto D'Ambrosio; Anna Crescenzi; Francesco Maria Di Matteo; Sergio Silvestri
Journal:  Lasers Med Sci       Date:  2016-05-04       Impact factor: 3.161

Review 6.  "Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.

Authors:  Jonathan B Bloom; Samuel A Gold; Graham R Hale; Kareem N Rayn; Vikram K Sabarwal; Ivane Bakhutashvili; Vladimir Valera; Baris Turkbey; Peter A Pinto; Bradford J Wood
Journal:  Gland Surg       Date:  2018-04

Review 7.  Magnetic Resonance-Guided Prostate Ablation.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Semin Intervent Radiol       Date:  2019-12-02       Impact factor: 1.513

8.  Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.

Authors:  Wei-Ching Lin; Valdair F Muglia; Gyl E B Silva; Salomão Chodraui Filho; Rodolfo B Reis; Antonio C Westphalen
Journal:  Br J Radiol       Date:  2016-03-23       Impact factor: 3.039

9.  MRI-Guided Robotically Assisted Focal Laser Ablation of the Prostate Using Canine Cadavers.

Authors:  Yue Chen; Sheng Xu; Alexander Squires; Reza Seifabadi; Ismail Baris Turkbey; Peter A Pinto; Peter Choyke; Bradford Wood; Zion Tsz Ho Tse
Journal:  IEEE Trans Biomed Eng       Date:  2017-09-26       Impact factor: 4.538

Review 10.  [Focal therapy for prostate cancer: German version].

Authors:  V Kasivisvanathan; T T Shah; I Donaldson; A Kanthabalan; C M Moore; M Emberton; H U Ahmed
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.